F. Hoffmann-La Roche Ltd, Abbott and Siemens Healthcare GmbH are Dominating the Global Lipid POCT Market in 2020

Global Lipid POCT Market is expected to grow with the CAGR of 5.12% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-lipid-poct-market

Global lipid POCT market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global lipid POCT market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, In October, Lonza unveiled its latest PyroCell MAT System to detect various pyrogens sensitively and sustainably, without the need for laboratory animals. The product was launched with a full solution with optimized MAT reagents from Sanquin and media and accessories from Lonza. The company's introduction of this new product has boosted its credibility and market demand.

F. Hoffmann-La Roche Ltd is the dominating player in global lipid POCT market. The other key players existing in the market include SD Biosensor,INC., PTS Diagnostics, Trinity Biotech, Nova Biomedical, Calligari Srl, AMD SOLUTIONS, EuroMedix, Siemens Healthcare GmbH (A Subsidiary of Siemens), TASCOM, General Life Biotechnology Co., Ltd., MICO BIOMED, Jant Pharmacal Corporation, Samsung Medison Co., Ltd., A. Menarini Diagnostics s.r.l, ACON Laboratories, Inc., PRIMA Lab SA, Quest Diagnostics Incorporated, and SKYLA CORPORATION among others.

Lipid POCT Market F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltd is headquartered in Basel, Switzerland was founded in 1896. The company is engaged in the developments of pharmaceuticals & diagnostics and also delivering personalized healthcare. They combine insights from multiple data sources to drive more effective and efficient research and allow for better therapeutic decisions for patients. The product categories of the company include Pharmaceuticals, Diagnostics, Personalized Healthcare in which market focused category is Diagnostics.

For instance,

  • In November 2020, F. Hoffmann-La Roche Ltd was recognized as the most suitable company by Dow Jones Sustainability Index. The recognition was based on the in depth analysis of social, economic and environmental performance. This will help company to further diversify its position in market and grow in coming years.

The company has presence in North America, South America, Europe, Middle East and Africa, Asia-Pacific. The company has various subsidiaries that are Genetech (U.S.), Spark Therapeutics (U.S.), Inflazome ltd. (Ireland), MYSugr GmBH (Austria), Ventana Medical Systems (U.S.) among others.

Abbott

Abbott is headquartered in Illinois, U.S. was founded in year 1888. The company is engaged in products in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help lead healthier lives. The product categories of the company include Healthcare Professionals, Consumers out of which Healthcare Professionals is market focused category.

For instance,

  • In December 2020, Abbott participated at the 39th Annual J. P. Morgan Healthcare Conference. This has helped the company to discuss about its best product which will help company to grow in coming years.

The company has wide global presence across North America, South America, Europe, Middle East and Africa, Asia-Pacific with its various subsidiaries such as Alere Inc. (U.S.), Abbott India Ltd (India), Panbio Ltd (U.S.), Abbott molecular Inc. (U.S.), Abbott Canada (Canada) among others.

Siemens Healthcare GmbH

Siemens Healthcare GmbH is headquartered in Munich, Germany and was founded in 1896. The company focuses on intelligent infrastructure for buildings and decentralized energy systems, on automation and digitalization in the process and manufacturing industries and on smart mobility solutions for rail and road transport. The product categories of the company include Value Partnership and Consulting, Medical Imaging, Laboratory Diagnostics, Point-of-Care-Testing, Services, Clinical Specialties, Accessories, OEMs & Electronics, Healthcare IT out of which Point-of-Care-Testing is market focused category.

For instance,

  • In August 2018, Siemens Healthcare GmbH inaugurated their new point of care diagnostics product manufacturing facility at Gujarat, India. This helped company to gain excellence in training for point of care testing and diagnostic products across Asia. This new site has also improved company’s patient care solutions over the lipid point of care testing market. It will also help the company in the diversification of its products and services and growth in the future.

The company has wide global presence across Asia-Pacific, Europe, Middle East and Africa, Americas.